Medicine Supply Notification: Bupropion (Zyban®) 150mg modified-release tablets
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Bupropion (Zyban®) 150mg modified-release tablets.
MSN/2022/100
Tier 3 – high impact
Date of issue 1st December 2022
- Bupropion (Zyban®) 150mg modified-release tablets will be out of stock until further notice.
- Various nicotine replacement therapies are available.
- NICE guidance highlights a range of other types of interventions to aid smoking cessation.
- Specialist advice is required on alternative products where bupropion is used off-label.
A copy of this medicine supply notification, including further information for pharmacy teams, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
